ViaWealth’s Thermo Fisher Scientific TMO Stock Holding History

ViaWealth’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$403K	Hold	820	–	–	0.22%	116
2025 Q4	$475K	Sell	820 -40	-5%	-$22.6K	0.27%	102
2025 Q3	$417K	Sell	860 -159	-16%	-$74K	0.23%	112
2025 Q2	$413K	Hold	1,019	–	–	0.24%	115
2025 Q1	$507K	Hold	1,019	–	–	0.31%	97
2024 Q4	$530K	Buy	1,019 +17	+2%	+$9.35K	0.32%	89
2024 Q3	$620K	Buy	1,002 +10	+1%	+$5.92K	0.36%	88
2024 Q2	$549K	Hold	992	–	–	0.34%	91
2024 Q1	$577K	Sell	992 -275	-22%	-$154K	0.36%	90
2023 Q4	$673K	Hold	1,267	–	–	0.46%	75
2023 Q3	$641K	Sell	1,267 -50	-4%	-$26.6K	0.47%	68
2023 Q2	$687K	Sell	1,317 -200	-13%	-$108K	0.51%	64
2023 Q1	$874K	Hold	1,517	–	–	0.69%	42
2022 Q4	$828K	Buy	+1,517	New	+$804K	0.68%	45

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ViaWealth's TMO Position: Q1 2026 in Review

ViaWealth held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 820 shares worth $403K. The position accounts for 0.22% of the portfolio, ranked #116.

ViaWealth first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $874K in Q1 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

ViaWealth held 820 shares of Thermo Fisher Scientific worth $403K as of Q1 2026.
ViaWealth left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.22% of ViaWealth's portfolio in Q1 2026, its #116 holding.
ViaWealth first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
ViaWealth's Thermo Fisher Scientific position peaked at $874K in Q1 2023.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on ViaWealth's 13F filing for Q1 2026, filed 11 May 2026.